PRESS RELEASE published on 03/14/2023 at 18:17, 3 years ago EQS-Adhoc: PharmaSGP Holding SE releases forecast for full year 2023
PRESS RELEASE published on 02/20/2023 at 07:30, 3 years 1 month ago PharmaSGP achieves new record revenue of more than € 85.5 million for 2022 exceeding analysts’ expectations
PRESS RELEASE published on 01/03/2023 at 16:13, 3 years 2 months ago EQS-Adhoc: PharmaSGP Holding SE resolves on buyback program for own shares of up to 1.5 million Euro
Published on 03/23/2026 at 02:00, 6 hours 1 minute ago FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 13:30, 2 days 18 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/23/2026 at 07:46, 14 minutes ago Delivery Hero to sell Taiwan food delivery operations to Grab for USD 600 million
Published on 03/23/2026 at 07:30, 31 minutes ago Nordex Group receives new order from Serbia for 70 MW
Published on 03/23/2026 at 07:30, 31 minutes ago Just – Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses
Published on 03/23/2026 at 07:30, 31 minutes ago Salzgitter Group delivers pretax result close to breakeven
Published on 03/23/2026 at 07:30, 31 minutes ago q.beyond intends to grow revenues to € 250 million by 2028 – “2028 Strategy” leverages sector focus, AI, and internationalisation
Published on 03/20/2026 at 19:00, 2 days 13 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 13 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 13 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 13 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
